SenesTech (NASDAQ:SNES) Shares to Reverse Split on Thursday, July 25th

SenesTech, Inc. (NASDAQ:SNES)’s stock is going to reverse split on the morning of Thursday, July 25th. The 1-10 reverse split was announced on Tuesday, July 23rd. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, July 24th.

SenesTech Trading Down 24.2 %

NASDAQ:SNES traded down $0.13 on Tuesday, hitting $0.41. 614,383 shares of the stock were exchanged, compared to its average volume of 294,917. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.69 and a current ratio of 6.91. The company’s 50-day moving average price is $0.64 and its 200 day moving average price is $0.78. SenesTech has a 52 week low of $0.40 and a 52 week high of $11.52.

SenesTech (NASDAQ:SNES) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). The company had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. During the same period last year, the company earned ($15.85) earnings per share. On average, equities research analysts forecast that SenesTech will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on SNES. StockNews.com began coverage on SenesTech in a research note on Saturday. They issued a “sell” rating for the company. HC Wainwright reaffirmed a “buy” rating and issued a $3.50 price target on shares of SenesTech in a research note on Tuesday, May 14th.

Institutional Trading of SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC bought a new position in shares of SenesTech, Inc. (NASDAQ:SNES) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned approximately 1.25% of SenesTech as of its most recent filing with the Securities and Exchange Commission. 5.19% of the stock is owned by institutional investors.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.